Anesthetic and perioperative considerations in liver disease (Non-transplant)

Randolph Steadman, Cinnamon Sullivan

Research output: Chapter in Book/Report/Conference proceedingChapter


The global prevalence of liver disease continues to increase and is currently the second leading cause of mortality in digestive disease in the U.S. The World Health Organization autopsy data shows that 4.5-9.5% of the general population has cirrhosis and the number of surgeries performed in the U.S. and worldwide is continuing to rise. Given the significant impact of anesthetic technique and intraoperative management on morbidity and mortality in this population, this chapter discusses the preoperative workup and optimization of end-stage liver disease (ESLD) patients. Procedures that are specific to ESLD and those commonly performed in ESLD are highlighted.

Original languageEnglish (US)
Title of host publicationHepatic Critical Care
PublisherSpringer International Publishing
Number of pages13
ISBN (Electronic)9783319664323
ISBN (Print)9783319664316
StatePublished - Jan 8 2018


  • Anesthesia and cirrhosis
  • Ascites
  • Bubble study
  • Cholecystectomy
  • Cirrhosis
  • Cirrhotic cardiomyopathy
  • Coagulopathy and cirrhosis
  • ERCP
  • Echocardiography
  • End-stage liver disease
  • Esophagoduodenoscopy
  • Factor concentrates
  • Hepatic encephalopathy
  • Hepatopulmonary syndrome
  • Hepatorenal syndrome
  • Hernia repair
  • Intravascular volume and cirrhosis
  • Liver failure
  • Portal decompression
  • Portal hypertension
  • Portopulmonary hypertension
  • Right heart function
  • Risk stratification and cirrhosis
  • Sphincteroplasty
  • Systolic pressure variation
  • TIPS
  • Thrombophilia and cirrhosis
  • Transfusion
  • Varices
  • Vasopressors and cirrhosis
  • Viscoelastic testing

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Anesthetic and perioperative considerations in liver disease (Non-transplant)'. Together they form a unique fingerprint.

Cite this